Chronic pain has a negative impact on sexuality in testis cancer survivors

Journal of Andrology

Volumn 33, Issue 5, 2012, Pages 886-893

  Pühse, Gerald ^a   Wachsmuth, Julia Urte ^a   Kemper, Sebastian ^a   Husstedt, Ingo W ^a   Evers, Stefan ^a   Kliesch, Sabine ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Ejaculation; Erectile dysfunction; Orchiectomy; Sexual dysfunction; Testicular germ cell cancer

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE;

ADULT; AGED; ARTICLE; CANCER SURVIVOR; CHRONIC PAIN; EJACULATION DISORDER; ERECTILE DYSFUNCTION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SEXUALITY; TESTIS CANCER; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CHI SQUARE DISTRIBUTION; EJACULATION; GERMANY; MIDDLE AGED; NEOPLASM; ORCHIECTOMY; ORGASM; PATHOPHYSIOLOGY; POSTOPERATIVE PAIN; PREMATURE EJACULATION; PSYCHOLOGICAL ASPECT; PSYCHOSEXUAL DISORDER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVOR; TESTIS TUMOR; TREATMENT OUTCOME;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; CHRONIC PAIN; EJACULATION; ERECTILE DYSFUNCTION; GERMANY; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; ORGASM; PAIN, POSTOPERATIVE; PENILE ERECTION; PREMATURE EJACULATION; PREVALENCE; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SEXUALITY; SURVIVORS; TESTICULAR NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874446824     PISSN: 01963635     EISSN: 19394640     Source Type: Journal    
DOI: 10.2164/jandrol.110.012500     Document Type: Article

References (29)

1. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Horwich A, Klepp O, Laguna MP, Pizzocaro G. Guidelines on testicular cancer. Eur Urol. 2005;48:885-894.
2. Albers P. Management of stage I testis cancer. Eur Urol. 2007;51:34-43.
3. Aubin S, Berger RE, Heiman JR, Ciol MA. The association between sexual function, pain, and psychological adaptation of men diagnosed with chronic pelvic pain syndrome type III. J Sex Med. 2008;5(3):657-667.
4. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology. 1999;54: 346-351.
5. Chaudhary UB, Haldas JR. Long-term complications of chemotherapy for germ cell tumours. Drugs. 2003;63:1565-1577.
6. Dahl AA, Bremnes R, Dahl O, Klepp O, Wist E, Fossa SD. Is the sexual function compromised in long-term testicular cancer survivors? Eur Urol. 2007;52:1438-1447.
7. Gerl A, Mühlbayer D, Hansmann G, Mraz W, Hiddemann W. The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors. Cancer. 2001;91:1297-1303.
8. Godfrey K. Comparing the means of several groups. In: Bailar JC, Mosteller F, eds. Medical Uses of Statistics. 2nd ed. Boston, MA: NEJM Books; 1992:233-257.
9. Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M. It's not over when it's over: long-term symptoms in cancer survivors-a systematic review. Int J Psychiatry Med. 2010;40(2):163-181.
10. Jonker-Pool G, Van de Wiel HBM, Hoekstra HJ, Sleijfer DT, van Driel MF, van Basten JP, Schraffordt Koops HS. Sexual functioning after treatment for testicular cancer-review and metaanalysis of 36 empirical studies between 1975-2000. Arch Sex Behavior. 2001;30:55-74.
11. Kwan KS, Roberts LJ, Swalm DM. Sexual dysfunction and chronic pain: the role of psychological variables and impact on quality of life. Eur J Pain. 2005;9(6):643-652.
12. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537-544.
13. Müller A, Mulhall JP. Sexual dysfunction in the patient with prostatitis. Curr Opin Urol. 2005;15(6):404-409.
14. Mykletun A, Dahl AA, O'Leary MP, Fossa SD. Assessment of male sexual function by the Brief Sexual Function Inventory. BJU Int. 2006;97(2):316-323.
15. Nazareth I, Lewin J, King M. Sexual dysfunction after treatment for testicular cancer: a systematic review. J Psychosom Res. 2001;51:735-743.
16. Nieschlag E, Swerdloff R, Behre HM. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl. 2006;27:135-137.
17. Nord C, Bjoro T, Ellingsen D, Mykletun A, Dahl O, Klepp O, Bremnes RM, Wist E, Fossa SD. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. Eur Urol. 2003;44:322-328.
18. O'Leary MP, Fowler FJ, Lenderking WR, Barber B, Sagnier PP, Guess HA, Barry MJ. A brief male sexual function inventory for urology. Urology. 1995;46:697-706.
19. Pühse G, Wachsmuth JU, Kemper S, Husstedt IW, Kliesch S, Evers S. Phantom testis syndrome: prevalence, phenomenology and putative mechanisms. Int J Androl. 2010;33:216-220.
20. Rhoden EL, Telöken C, Sogari PR, Souto CA. The relationship of serum testosterone to erectile function in normal aging men. J Urol. 2002a;167:1745-1748.
21. Rhoden EL, Telöken C, Sogari PR, Vargas Souto CA. The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int J Impot Res. 2002b;14:245-250.
22. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822-830.
23. Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol. 2004;15:1377-1399.
24. Shabsigh R. Hypogonadism and erectile dysfunction: the role for testosterone therapy. Int J Impot Res. 2003;15(4):9-13.
25. Sörös P, Vo O, Husstedt IW, Evers S, Gerding H. Phantom eye syndrome: its prevalence, phenomenology, and putative mechanisms. Neurology. 2003;60:1542-1543.
26. Tinkler SD, Howard GC, Kerr GR. Sexual morbidity following radiotherapy for germ cell tumours of the testis. Radiother Oncol. 1992;25:207-212.
27. Tuinman MA, Hoekstra HJ, Vidrine DJ, Gritz ER, Sleijfer DT, Fleer J, Hoekstra-Weebers JE. Sexual function, depressive symptoms and marital status in nonseminoma testicular cancer patients: a longitudinal study. Psychooncology. 2010;19(3):238-247.
28. van Basten JP, Schrafford Koops H, Sleijfer DT, Pras E, van Driel MF, Hoekstra HJ. Current concepts about testicular cancer. Eur J Surg Oncol. 1997;23:354-360.
29. Verstappen CC, Heimans JJ, Hoekman K, Postma TJ. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs. 2003;63:1549-1563.